CONSIDERATIONS TO KNOW ABOUT IS ABBV-744 EFFECTIVE FOR HEMATOLOGIC CANCERS?

In Segment A, participants will acquire unique doses and schedules of oral ABBV-744 tablet to identify safe dosing regimen. Additional contributors might be enrolled with the recognized monotherapy dosign program. In Section B, contributors will get oral ruxolitinib and ABBV-744 will be specified as "incorporate-on" therapy. In Segment C, members w